With an increasing number of individuals opting for COVID-19 vaccinations, the pandemic's spread is waning, shifting the focus towards understanding "COVID long haulers" who continue to experience symptoms post-infection.
The pursuit of drug therapy as a treatment for hearing loss is an ongoing area of exploration, yet substantial breakthroughs remain elusive, and viable solutions appear distant.
